Part I: Key Topics for Product Development: Devices, Biologics and Drugs
Click/Tap a chapter title to enter
| I.1 | A Needs-Based Approach to Health Technology Innovation: The Stanford Biodesign Process |
| Jonathan G Schwartz MD, Paul G Yock MD, Uday N Kumar MD, and Todd J Brinton, MD |
|
| I.2 | Intellectual Property and Strategy Development |
| Neil K Nydegger Esq | |
| I.3 | Investigational and New Cardiovascular Devices: Strategy and Decision-Making for Reimbursement in the Post-Reform Era |
| John C Lewin MD, Janna Crittendon, Louis Garrison PhD and Larry McNeely |
|
| I.4 | Sources of Funding for Early Stage Ventures |
| Ron King PhD MBA and MaryAnn Guerra MBA | |
| I.5 | Anesthesia and Care of the Large Animal for Survival Studies: Sheep |
| Cheryl Blaze BVSc PhD MBA | |
| I.6 | Anesthesia and Care of the Large Animal for Survival Studies: Pig |
| Cheryl Blaze BVSc PhD MBA | |
| I.7 | Echocardiography in Translational Research |
| Pierre Monney MD, Xavier Jeanrenaud MD, Hendrick Tevaearai MD EMBA and Didier Locca MD |
|
| I.8 | MRI in Translational Research |
| Andrew J Ludman MD, Stéphanie M Perruchoud Fluri MD, Juan F Iglesias MD, Anthony Mathur PhD and Didier Locca MD |
|
| I.9 | Biomarkers in Cardiovascular Medicine |
| Christiane Chène PhD, Sarah Longnus PhD and Hendrik Tevaearai MD EMBP |
|
| I.10 | Clinical Study Design for Translational Research |
| Christopher M Mullin MS and Scott Brown PhD |